https://www.mahzooz.ae/
https://www.mahzooz.ae/
As a bright young student, Saad Syed was drawn to medicine and was overjoyed to learn he had been awarded a scholarship from Al Jalila Foundation to continue his studies at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU).
By attaining this scholarship, Saad can follow his passion for medicine and he finds himself developing every day. Saad’s medical student experience has truly enriched his life and encouraged him to develop life skills such as problem solving and empathy which has allowed his creativity to shine through.
At MBRU Saad has a rich student life and engages in several programs including the Summer Scholar’s program which allows students to explore their passions by participating in clinical observerships, clinical research and volunteering at local and international hospitals and institutes to broaden their vision of healthcare of today.
Through his experiences Saad recognised a large gap in the field of research and developed a strong passion for innovation. Saad hopes to work in the field of medical education and produce relevant research papers and is enthusiastic to take a proactive role in medicine.
“My ultimate goal is open but I believe that with technology advancing exponentially the roles of doctors will be vastly different from what they are today, and I hope to fulfill those responsibilities and expectations of the doctor of the future.”
Nahid Al-Naqbi, a celebrated journalist for Al Bayan Newspaper and a recipient of the 2018 Al Jalila Foundation Rosalynn Carter Fellowship for Mental Health Journalism, is recovering from breast cancer thanks to receiving quality medical care and support.
Nahid’s journey has not been easy and whilst she does not define her life by her cancer – in Nahid’s words “Cancer was part of my life. But it is not my life.” – her diagnosis inspired her to be a passionate advocate for cancer research and access to quality care for cancer patients.
Through the newly launched Bassmat Rashid Bin Saeed giving campaign Nahid saw the perfect opportunity to champion medical research to save patients’ lives. Nahid rallied her high school friends ‘Girls of Khor Fakkan Class of 96’ and together they raised AED 20,000 to kick-start Nahid’s mission.
The ambassadors of hope paid a special visit to Al Jalila Foundation to make the donation and engrave their class name live on the donor recognition wall leaving their mark on the future of medicine.
Nahid’s work does not stop there, she is on a mission to reach zero cancer deaths by 2030 and has launched an ambitious YallaGive fundraising campaign to raise AED 500,000 to support breast cancer research in the UAE.
Follow Nahid’s inspiring journey on Instagram and support her #ZeroBy2030 campaign here.
Autism spectrum disorder (ASD) is a growing health concern around the world and is estimated that it impacts 1 in every 58 children globally. Research indicates that the disease manifests very early in development which requires early diagnosis and intervention.
Dr Mohammed Uddin from Mohammed Bin Rashid University of Medicine and Health Sciences, an expert in the etiology of autism and neurodevelopmental disorder genetics, is leading a study to develop ‘An in vitro system to characterise recurrent pathogenic deletions in autism spectrum disorder’.
Each child impacted by autism carries a different genetic signature; therefore, a targeted personalised molecular approach is necessary. This research is immensely important to implement a translational core for autism genome and to guide personalised therapeutics. Dr Uddin hopes this study will be a step forward for genome sequencing projects and will enable the translation of clinical relevance of the mutated genes.
The team now have a comprehensive list of genes that are associated with ASD and have successfully completed gene editing experiments. Due to the relevant and important nature of the work, Al Jalila Foundation has funded this research to continue the process of conducting multiple characterisation experiments on the knockout CRISPR/Cas9 cell lines that can then be used by other scientists in the country.
To learn more about this and other Al Jalila Foundation research please click here.
December 2020
This year began with an unprecedented global health crisis, the coronavirus (COVID-19) pandemic, which has affected every person around the world. 2020 has certainly tested us all as it brought our world to a complete standstill as we experienced movement restrictions, many lost their livelihoods and, sadly, some even their loved ones. And even so, despite the losses and the challenges we have faced, we have witnessed great learning, incredible innovation and, more than anything else, a united global front and togetherness to fight the virus
At 4-years-old Bismah, a highly talented child, began to develop serious health problems and deteriorated to the point that she could no longer walk or play like other children. After admission to the hospital she was diagnosed with a very rare autoimmune connective tissue disease, juvenile dermatomyositis, in which only 1 to 4 cases occur per million children. As a connective tissue disease, if left untreated it can cause significant disability and high-risk mortality. Patients must undergo rigorous medical care under close supervision to stabilise their condition and support their recovery.
Coincidently, in addition to this rare disease she was also diagnosed with type 1 diabetes mellitus which too had developed complications and required vital treatment and care. The medical team at Al Jalila Children’s Specialty Hospital put together an extensive treatment plan for Bismah and Al Jalila Foundation provided the financial support the family needed to save their daughter’s life.
The family has expressed their gratitude: “We cannot say thank you enough for the support Al Jalila Foundation has been to our daughter. She has transformed from when she arrived at the hospital unable to stand and she then came back home running.”
Bismah is responding to the treatment well and is a happy care-free child.
Despite the high prevalence of type 2 diabetes in the UAE, approximately 1 in 5 of the population suffers from the disease, epidemiological data about diabetes incidence and subgroups in the UAE in general, and particularly the Northern Emirates (Sharjah/Ajman), is very limited.
Al Jalila Foundation research grant recipient Professor Nabil Sulaiman from University of Sharjah is leading a pioneering local research study ‘All new diabetics in Sharjah & Ajman [ANDISA]: An epidemiological and genetic study toward individualized medicine (phase II)’ to find answers.
Clinical data such as the response of diabetes subgroups to different modes of treatment and the prevalence of diabetes complications in these subgroups have not been investigated yet.
This study aims to enroll new diabetic patients aged 13 to 65 years in Sharjah and Ajman to collect basic, clinical, genetic and immunological data from a newly diagnosed population of diabetics to improve diagnostic categorisation rates and develop personalised treatment.
This groundbreaking study represents the first step towards precision medicine in diabetes in the UAE. Through the findings it will provide better diagnosis and better personalised care for diabetic patients at a lower cost.
It is through investing in studies like this, Al Jalila Foundation aims to create a brighter future for diabetic patients.
To read more about this and other research click here.
Al Jalila Foundation, a global philanthropic organisation dedicated to transforming lives through medical education and research, announced today that it has awarded AED2.5 million in seed grants to five UAE-based medical researchers. The COVID-19 research grants in the areas of genetics, therapies and diagnosis are the first to be awarded under the auspices of the recently inaugurated Mohammed Bin Rashid Medical Research Institute to help enhance the UAE’s capacity to address the pandemic and other viral diseases in the future.
The research awards were presented by His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Chairman of Dubai’s Supreme Committee of Crisis and Disaster Management, during a ceremony at Al Jalila Foundation.
The award recipients are highly talented scientists from some of the most prestigious medical institutions in the UAE including United Arab Emirates University, University of Sharjah, Al Ain University and Al Jalila Children’s Specialty Hospital.
During the event, Al Jalila Foundation engraved the name of His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum on a first-of-its-kind donor recognition wall called Bassmat Rashid Bin Saeed. The donor recognition wall pays tribute to the late Sheikh Rashid bin Saeed Al Maktoum’s philanthropic legacy and honours generous donors who invest in medical research.
His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairperson of the Board of Trustees of Al Jalila Foundation, said the Foundation’s efforts to advance medical research support the UAE leadership’s vision for the future of healthcare and the high priority they place on scientific and medical fields.
“The Foundation’s initiatives reflect its strong commitment to enhancing the capabilities of the country’s healthcare system by supporting research organisations and talented scientists as well as forging cooperation with international research entities and public and private sector institutions in the UAE. The Al Jalila Foundation is keen to work with medical institutions to enhance the UAE’s readiness to face health challenges, the most critical of which is the COVID-19 pandemic. At a time when the world is racing against time to find solutions for eradicating the virus, well-funded research efforts are critical to mitigate current and future health and economic challenges,” he added.
His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum praised the efforts of Al Jalila Foundation and the researchers who received grants for their commitment to advancing research to combat COVID-19.
His Highness said: “Dubai is committed to supporting research in healthcare and medical fields as part of the vision of Vice President and Prime Minister of the UAE and Ruler of Dubai HH Sheikh Mohammed bin Rashid Al Maktoum to transform the UAE’s growth and development through new knowledge and innovation. Exploring new possibilities and breakthrough discoveries in healthcare and medical sectors is key to the UAE’s and Dubai’s efforts to create future-ready economic and social systems that are geared to meet the evolving needs of a post-COVID world. Al Jalila Foundation’s efforts to promote COVID-19 research is consistent with Dubai’s strong strategic focus on these sectors and its commitment to creating long term value by advancing the frontiers of learning and science.”
Her Excellency Dr. Raja Al Gurg, Member of the Board of Trustees of Al Jalila Foundation and Chairperson of the Board of Directors of Al Jalila Foundation, commented: “We are proud to support the nation’s efforts to combat COVID-19. These research awards are testament to our commitment to adapting to the changing needs of the medical landscape to ensure the health and safety of our people. “Our investment in medical research reaffirms our commitment to embed research and innovation in the fabric of the nation’s long-term healthcare strategy.”
“By supporting talented scientists and investing in research, we are developing the next generation of innovators in health sciences and paving the way for medical breakthroughs to save lives.” Dr Raja added.
The applications were assessed through a competitive two-stage review process that included independent international peer reviews by experts from the world’s most renowned medical institutions across the globe from USA, Belgium, Norway, Brazil, Japan, Singapore, Italy, India, UK, and Australia. The process was overseen by the Al Jalila Foundation Scientific Advisory Committee which is made up of some of the most brilliant minds in the region. They worked with an international peer review panel to award research grants to the most deserving scientists. The reviewers were handpicked as leading experts in their specific field of research, in line with the commitment from Al Jalila Foundation to grow a biomedical research ecosystem in Dubai built on international best practice.
Out of 91 applications, five were selected to receive grants of up to AED500,000 each.
Dr Abdulkareem Sultan Al Olama, CEO of Al Jalila Foundation, added: “The COVID-19 global outbreak has amplified the need to invest in pioneering medical research. Now, more than ever, we are counting on scientists and doctors coming together to develop better diagnostic testing, treatments, and gain a better understanding of the coronavirus and other viral diseases. We are delighted with the incredible response we have received from the scientific community and confident about the contributions this round of research grants can make to support the fight to combat COVID-19.”
Each research project has strong collaborations with scientists and researchers in the UAE and abroad, with the engagement of over 40 co-investigators from renowned research institutions across the globe. Collectively, the principal investigators have co-authored over 300 peer-reviewed publications in prestigious international journals. The research projects comprise of multidisciplinary teams of clinicians, scientists, and medical students from major academic and health entities in the UAE and abroad, including geneticists, epidemiologists, pediatricians, infectious disease specialists, microbiologists, pulmonologists, and such. They have outstanding expertise and resources to contribute to Al Jalila Foundation’s mission to support the UAE Government in its fight against COVID-19.
Since inception in 2013, Al Jalila Foundation, a member of the Mohammed Bin Rashid Global Initiatives, has provided opportunities to increase innovative and impactful medical research investing AED28 million to award 101 research grants and eight international research fellowships at leading global institutions in the UK, USA and Japan to discover solutions for the region’s biggest health challenges.
Summary of research projects that received grants:
Diagnosis
Dr. Farah Mustafa, from United Arab Emirates University, aims to characterize microRNAs induced during different stages of COVID-19 as biomarkers for better diagnosis, disease prognosis, and development of novel RNA-based therapies against COVID-19.
Genetics
Professor Rabih Halwani, from University of Sharjah, is determining inborn errors of immunity associated with life-threatening COVID-19 infections in previously healthy young individuals.
Dr. Ahmad Abou Tayoun, from Al Jalila Children’s Specialty Hospital, is studying the genetics of COVID-19 in children and young adults in the UAE.
Therapies
Professor Taleb H. Al-Tel, from University of Sharjah, aims to develop novel and nature-inspired therapeutics for the treatment of COVID-19 by inhibiting the proteins and enzymes of the virus that are responsible for host-cells entry and for the replication of the virus inside the human cells.
Dr. Mohammad Ghattas, from Al Ain University, is discovering new drug candidates as potential treatments for COVID-19 via targeting the main protease enzyme (Mpro) of the virus.
November 2020
Today, I am excited to share the progress Al Jalila Foundation is making in our continued efforts and commitment to advance medical breakthroughs to transform lives. This unprecedented year called on us to address and be a part of the solution to the COVID-19 pandemic and we responded by opening a dedicated research cycle. We are proud to announce that we have just awarded the first Mohammed Bin Rashid Medical Research Institute grants to 5 scientists investigating ways to combat the Coronavirus disease
Among many of the challenges faced this year, education and distance learning has been one of the hardest. Hundreds of thousands of students in the UAE embarked on online learning for the first time, many of whom were children of determination who require a little extra care and support. This meant parents around the country desperately needed better tools and understanding to continue to support their children through these unprecedented times.
In line with the Ta’alouf program values to empower parents and teachers of children of determination, Al Jalila Foundation hosted a live webinar presented by Autism Specialist Teacher and Certified Trainer Shaikha Salem AlKaabi from Zayed Higher Organization for People of Determination. The webinar focused on exploring the most important strategies to help children with autism spectrum disorder adapt to their environment, including preparing a structured schedule and a productive routine for them while studying at home.
The webinar was attended by more than 350 parents from 17 countries all eager to do their best to support their children through home schooling.
Shaikha AlKaabi was encouraged by the participation and said: “These wonderful parents gained tangible benefits from the online workshop and can now use their skills to prepare activities so their children continue to flourish during these difficult times.”